After a fourth quarter in which revenue boomed throughout the biopharma industry, there were reversals for several drugmakers ...

Eli Lilly acquires SiteOne Therapeutics for up to $1B, signaling potential uptick in Big Pharma deals and focus on non-opioid ...

President Trump's funding cuts to Harvard threaten the university's position as the world's leading research institution. The next 10 are all in China.

SiteOne Therapeutics is developing a non-opioid therapy that targets sodium ion channels in the human body to treat pain and ...

Crain's list of the Chicago area's largest publicly traded companies is back for 2025 with Walgreens Boots Alliance topping the rankings for likely the last time. The Deerfield-ba ...

Investors are always encouraging startups to push the innovation envelope. General Catalyst’s Hemant Taneja is applying that ...